의료진

스킵네비게이션

본문바로가기
주메뉴바로가기

기타
With 울산대학교병원

기타

의료진

기타의료진

심장내과박경민(심장병원 병원장)

진료분야협심증,심근경색,흉통,고혈압,고지혈증,말초동맥질환,대동맥질환

예약하기

진료일정 5월 6월 선택됨 6월

진료일정의 경우, 휴진 및 진료과의 사정으로 변경될 수 있으니 확인 후 내원해주시기 바랍니다.

이전달 다음달

박경민 진료일정표
날짜	1 일	2 월	3 화	4 수	5 목	6 금	7 토	8 일	9 월	10 화	11 수	12 목	13 금	14 토	15 일	16 월	17 화	18 수	19 목	20 금	21 토	22 일	23 월	24 화	25 수	26 목	27 금	28 토	29 일	30 월
오전
오후

진료 클리닉 휴진

학력
- 울산대학교 의과대학 의학과 졸업
- 울산대학교 의과대학 대학원 의학석사
- 울산대학교 의과대학 대학원 의학박사
경력
- 서울아산병원 인턴
- 서울아산병원 내과 전공의
- 서울아산병원 심장내과 임상강사
- 가톨릭대학교 대전성모병원 심장내과 조교수
- 울산대학교병원 심장내과 부교수
- 울산대학교병원 심장내과 교수
직책
- 심장병원 병원장
- 가슴통증센터장
- 분과장
- 디지털혁신본부장
- 빅데이터센터장

Lee H, Ha J, Park KS, Jeon YJ, Park S, Ann SH, Kim YG, Lee Y, Kwon WJ, Choi SH, Han S, Park GM. Association between smoking status and subclinical coronary atherosclerosis in asymptomatic individuals. Epidemiol Health. 2024 Jul 16:e2024064.
Lee H, Park KS, Jeon YJ, Park EJ, Park S, Ann SH, Kim YG, Lee Y, Choi SH, Park GM. Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals. Atherosclerosis. 2022 May;349:190-195.
Ann SH, Lee H, Park KS, Jeon YJ, Park EJ, Park S, Kim YG, Lee Y, Choi SH, Kwon WJ, Park GM. Marital Status and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals. J Am Heart Assoc. 2022 Jun 7;11(11):e024942.
Park KS, Lee H, Jeon YJ, Park S, Ann SH, Kim YG, Lee Y, Park J, Choi SH, Park GM. Serum phosphorus and subclinical coronary atherosclerosis in asymptomatic subjects without kidney dysfunction. Clin Nephrol. 2022 Aug;98(2):83-91.
Lee K, Han S, Lee M, Kim DW, Kwon J, Park GM, Park MW. Evidence-Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention. J Am Heart Assoc. 2023 May 16;12(10):e024370.
Park S, Kim YG, Ann SH, Cho YR, Kim SJ, Han S, Park GM. Epidemiol Health. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population. 2023;45:e2023052.
Park S, Jeon YJ, Ann SH, Kim YG, Lee Y, Choi SH, Han S, Park GM. Comprehensive Prediction of Subclinical Coronary Atherosclerosis in Subjects Without Traditional Cardiovascular Risk Factors. Am J Cardiol. 2023 Jul 1;198:64-71.
Park HW, Jo S, Park KS, Lee H, Jeon YJ, Park S, Ann SH, Kim YG, Choi SH, Kwon WJ, Cho YR, Suh J, Park GM. Differential Impact of Degree of Hypertension on Subclinical Coronary Atherosclerosis in Asymptomatic Subjects With and Without Diabetes Mellitus. Am J Cardiol. 2023 Sep 15;203:343-351.
Park S, Chang J, Hong SP, Jin ES, Kong MG, Choi HY, Kwon SS, Park GM, Park RW. Impact of Trimetazidine on the Incident Heart Failure After Coronary Artery Revascularization. J Cardiovasc Pharmacol. 2023 Oct 1;82(4):318-326.
Park J, Lee H, Jeon YJ, Park EJ, Park S, Ann SH, Kim YG, Lee Y, Park GM, Choi SH. Depression and Subclinical Coronary Atherosclerosis in Adults Without Clinical Coronary Artery Disease. J Am Heart Assoc. 2023 Dec 19;12(24):e030315.
Park S, Kim YG, Ann SH, Park HW, Suh J, Roh JH, Cho YR, Han S, Park GM. Angiotensin-Converting Enzyme Inhibitor-based Versus Angiotensin Receptor Blocker-based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study. J Cardiovasc Pharmacol. 2021 Jan 1;77(1):61-68.
Park J, Park S, Kim YG, Ann SH, Park HW, Suh J, Roh JH, Cho YR, Han S, Park GM. Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention. Sci Rep. 2021 Apr 21;11(1):8600.
Park HW, Kim YG, Park GM, Park S, Cho YR, Suh J, Lee Y, Yang DH, Kang JW, Kim HK, Choe J, Kim YH, Lee SW. Cholesterol Control for Subclinical Coronary Atherosclerosis in Subjects Without Indication for Statin Therapy. Am J Cardiol. 2021 Aug 15;153:51-57.
Lee H, Jeon YJ, Kang BJ, Lee TY, Park EJ, Park S, Ann SH, Kim YG, Lee Y, Choi SH, Park GM. Frequency and Significance of Right Bundle Branch Block and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals. Am J Cardiol. 2021 Nov 1;158:30-36.
Park S, Kim YG, Ann SH, Park HW, Suh J, Roh JH, Cho YR, Han S, Park GM. Ticagrelor versus prasugrel in patients with acute myocardial infarction. Int J Cardiol. 2021 Dec 1;344:25-30.
Park GM, Cho YR, Won KB, Yang YJ, Park S, Ann SH, Kim YG, Park EJ, Kim SJ, Lee SG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020 Jan 14;19(1):7.
Park S, Park GM, Ha J, Cho YR, Roh JH, Park EJ, Yang Y, Won KB, Ann SH, Kim YG, Kim SJ, Lee SG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals. PLoS One. 2020 Apr 8;15(4):e0231428.
Ann SH, Strauss MH, Park GM, Han S, Yang Y, Kim YG, Won KB, Kim SJ, Lee SG, Cho YR, Kim DW, Park MW, Her SH, Lee SW. Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention. Int J Cardiol. 2020 May 1;306:35-41.
Park GM, Lee CH, Lee SW, Yun SC, Kim YH, Kim YG, Won KB, Ann SH, Kim SJ, Yang DH, Kang JW, Lim TH, Koh EH, Lee WJ, Kim MS, Park JY, Kim HK, Choe J, Lee SG. Impact of Diabetes Control on Subclinical Atherosclerosis: Analysis from Coronary Computed Tomographic Angiography Registry. Diabetes Metab J. 2020 Jun;44(3):470-479.
Park GM, Lee JH, Choi SW, Jeong JO, Shin ES, Bae JW, Yoon HJ, Jung KT, Baek JY, Choi WG, Choi RK, Her SH, Lee JB, Suh J, Lee JB, Lee SW, Chae IH, Choi SY, Seong IW. Additional postdilatation using noncompliant balloons after everolimus-eluting stent implantation: Results of the PRESS trial. Clin Cardiol. 2020 Jun;43(6):606-613.
Park KS, Lee Y, Park GM, Park JH, Kim YG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Association between serum phosphorus and subclinical coronary atherosclerosis in asymptomatic Korean individuals without kidney dysfunction. Am J Clin Nutr. 2020 Jul 1;112(1):66-73.
Kim YG, Park GM, Lee SB, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics. Sci Rep. 2020 Oct 22;10(1):17994.
Lee PH, Park GM, Han S, Kim YG, Lee JY, Roh JH, Lee JH, Kim YH, Lee SW. Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management. Sci Rep. 2020 Dec 17;10(1):22121.
Won KB, Park GM, Yang YJ, Ann SH, Kim YG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH, Kim SJ, Lee SG. Independent role of low-density lipoprotein cholesterol in subclinical coronary atherosclerosis in the absence of traditional cardiovascular risk factors. Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):866-872.
Lim DH, Lee Y, Park GM, Choi SW, Kim YG, Lee SW, Kim YH, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Hong S, Kim YG, Lee CK, Yoo B. Serum uric acid level and subclinical coronary atherosclerosis in asymptomatic individuals: An observational cohort study. Atherosclerosis. 2019 Jul 19;288:112-117.
High HDL-C levels reduce the risk of obstructive coronary artery disease in asymptomatic diabetics who achieved optimal glycemic control. Park GM, Lee Y, Won KB, Yang YJ, Park S, Ann SH, Kim YG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH, Kim SJ, Lee SG. Sci Rep. 2019 Oct 25;9(1):15306.
Lee CH, Lee JY, Park GM, Lee SW, Kim HS, Choi YJ, Nam CW, Cho JH, Shin WY, Seo JB, Choi SW, Lee JH, Min PK, Her SH, Lee PH, Ahn JM, Park DW, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ. Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial. Am J Cardiol. 2018 Feb 15;121(4):423-429.
Lee SB, Park GM, Lee JY, Lee BU, Park JH, Kim BG, Jung SW, Jeong ID, Bang SJ, Shin JW, Park NH, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee HC. Association between nonalcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study. J Hepatol. 2018 May;68(5):1018-1024.
Han S, Park GM, Kim YG, Park MW, Her SH, Lee SW, Kim YH. Trends, Characteristics, and Clinical Outcomes of Patients Undergoing Percutaneous Coronary Intervention in Korea between 2011 and 2015. Korean Circ J. 2018 Apr;48(4):310-321.
Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018 Nov 24;17(1):268.
Han S, Park GM, Kim YG, Hwang KW, Roh JH, Won KB, Ann SH, Kim SJ, Lee SG. Effect of atrial fibrillation in Asian patients undergoing percutaneous coronary intervention with drug-eluting stents for stable coronary artery disease: Results from a Korean nationwide study. Medicine (Baltimore). 2018 Nov;97(48):e13488.
Yang Y, Park GM, Han S, Kim YG, Suh J, Park HW, Won KB, Ann SH, Kim SJ, Kim DW, Park MW, Her SH, Lee SG. Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study. PLoS One. 2018 Dec 10;13(12):e0208746.
Park MW, Park GM, Han S, Yang Y, Kim YG, Roh JH, Park HW, Suh J, Cho YR, Won KB, Ann SH, Kim SJ, Kim DW, Her SH, Lee SG. Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis. PLoS One. 2018 Dec 7;13(12):e0207889.
Park GM, Cho YR, Lee SW, Yun SC, Won KB, Ann SH, Kim YG, Kim SJ, Roh JH, Kim YH, Yang DH, Kang JW, Lim TH, Jung CH, Koh EH, Lee WJ, Kim MS, Lee KU, Park JY, Kim HK, Choe J, Lee SG. Prediabetes is not a risk factor for subclinical coronary atherosclerosis. Int J Cardiol. 2017 Sep 15;243:479-484.
Lee PH, Park GM, Kim YH, Yun SC, Chang M, Roh JH, Yoon SH, Ahn JM, Park DW, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ. Effect of Beta Blockers and Renin-Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Medicine (Baltimore). 2016 Mar;95(10):e2971.
Park GM, Kim YH, Yun SC, Ahn JM, Choi HI, Roh JH, Lee PH, Chang M, Lee SG, Jo MW, Park DW, Kang SJ, Lee SW, Lee CW, Moon DH, Park SW, Park SJ. Anatomical or Functional Evaluation as an Initial Test for Stable Coronary Artery Disease: A Propensity Score Analysis. J Nucl Med. 2016 Sep;57(9):1364-9.
Kang SH, Park GM, Lee SW, Yun SC, Kim YH, Cho YR, Park HW, Suh J, Yang DH, Kang JW, Lim TH, Jung CH, Koh EH, Lee WJ, Kim MS, Lee KU, Park JY. Long-Term Prognostic Value of Coronary CT Angiography in Asymptomatic Type 2 Diabetes Mellitus. JACC Cardiovasc Imaging. 2016 Nov;9(11):1292-1300.
Park GM, Yun SC, Cho YR, Gil EH, Her SH, Kim SH, Jo MW, Lee MS, Lee SW, Kim YH, Yang DH, Kang JW, Lim TH, Kim BJ, Koh JM, Kim HK, Choe J, Park SW, Park SJ. Prevalence of coronary atherosclerosis in an Asian population: findings from coronary computed tomographic angiography. Int J Cardiovasc Imaging. 2015 Mar;31(3):659-68.
Park GM, An H, Lee SW, Cho YR, Gil EH, Her SH, Kim YH, Lee CW, Koh EH, Lee WJ, Kim MS, Lee KU, Kang JW, Lim TH, Park SW, Park SJ, Park JY. Risk score model for the assessment of coronary artery disease in asymptomatic patients with type 2 diabetes. Medicine (Baltimore). 2015 Jan;94(4):e508.
Park GM, An H, Lee SW, Cho YR, Gil EH, Her SH, Park HW, Ahn JM, Park DW, Kang SJ, Kim YH, Lee CW, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Park SW, Park SJ. Impact of Metabolic Syndrome on Subclinical Atherosclerosis in Asymptomatic Individuals. Circ J. 2015 Jul 24;79(8):1799-806.
Park GM, Kim SH, Jo MW, Her SH, Han S, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Lee CW, Kim BJ, Koh JM, Kim HK, Choe J, Park SW, Park SJ. Clinical impact and cost-effectiveness of coronary computed tomography angiography or exercise electrocardiogram in individuals without known cardiovascular disease. Medicine (Baltimore). 2015 May;94(21):e917.
Park GM, Lee JH, Lee SW, Yun SC, Kim YH, Cho YR, Gil EH, Kim TS, Kim CJ, Cho JS, Park MW, Her SH, Yang DH, Kang JW, Lim TH, Koh EH, Lee WJ, Kim MS, Lee KU, Kim HK, Choe J, Park JY. Comparison of Coronary Computed Tomographic Angiographic Findings in Asymptomatic Subjects With Versus Without Diabetes Mellitus. Am J Cardiol. 2015 Aug 1;116(3):372-8.
Park GM, Cho YR, Lee SW, Yun SC, Gil EH, Kim DW, Kim TS, Kim CJ, Cho JS, Park MW, Her SH, Kim YH, Yang DH, Kang JW, Lim TH, Jung CH, Koh EH, Lee WJ, Kim MS, Lee KU, Kim HK, Choe J, Park JY. Family history of diabetes and the risk of subclinical atherosclerosis. Diabetes Metab. 2016 Jun;42(3):170-7.
Park GM, Kim YH. Model for Predicting Cardiovascular Disease: Insights from a Korean Cardiovascular Risk Model. Pulse (Basel). 2015 Sep;3(2):153-7.
Park GM, Yun SC, Cho YR, Gil EH, Her SH, Kim SH, Jo MW, Lee MS, Lee SW, Kim YH, Yang DH, Kang JW, Lim TH, Kim BJ, Koh JM, Kim HK, Choe J, Park SW, Park SJ. Prevalence of coronary atherosclerosis in an Asian population: findings from coronary computed tomographic angiography. Int J Cardiovasc Imaging. 2015 Mar;31(3):659-68.
Park GM, An H, Lee SW, Cho YR, Gil EH, Her SH, Kim YH, Lee CW, Koh EH, Lee WJ, Kim MS, Lee KU, Kang JW, Lim TH, Park SW, Park SJ, Park JY. Risk score model for the assessment of coronary artery disease in asymptomatic patients with type 2 diabetes. Medicine (Baltimore). 2015 Jan;94(4):e508.
Park GM, An H, Lee SW, Cho YR, Gil EH, Her SH, Park HW, Ahn JM, Park DW, Kang SJ, Kim YH, Lee CW, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Park SW, Park SJ. Impact of Metabolic Syndrome on Subclinical Atherosclerosis in Asymptomatic Individuals. Circ J. 2015 Jul 24;79(8):1799-806.
Park GM, Kim SH, Jo MW, Her SH, Han S, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Lee CW, Kim BJ, Koh JM, Kim HK, Choe J, Park SW, Park SJ. Clinical impact and cost-effectiveness of coronary computed tomography angiography or exercise electrocardiogram in individuals without known cardiovascular disease. Medicine (Baltimore). 2015 May;94(21):e917.
Park GM, Lee JH, Lee SW, Yun SC, Kim YH, Cho YR, Gil EH, Kim TS, Kim CJ, Cho JS, Park MW, Her SH, Yang DH, Kang JW, Lim TH, Koh EH, Lee WJ, Kim MS, Lee KU, Kim HK, Choe J, Park JY. Comparison of Coronary Computed Tomographic Angiographic Findings in Asymptomatic Subjects With Versus Without Diabetes Mellitus. Am J Cardiol. 2015 Aug 1;116(3):372-8.
Park GM, Cho YR, Lee SW, Yun SC, Gil EH, Kim DW, Kim TS, Kim CJ, Cho JS, Park MW, Her SH, Kim YH, Yang DH, Kang JW, Lim TH, Jung CH, Koh EH, Lee WJ, Kim MS, Lee KU, Kim HK, Choe J, Park JY. Family history of diabetes and the risk of subclinical atherosclerosis. Diabetes Metab. 2016 Jun;42(3):170-7.
Park GM, Kim YH. Model for Predicting Cardiovascular Disease: Insights from a Korean Cardiovascular Risk Model. Pulse (Basel). 2015 Sep;3(2):153-7.
Park GM, Park DW, Kim YG, Cho SW, Sun BJ, Hwang KW, Kim YR, Ahn JM, Song HG, Kim WJ, Lee JY, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park SJ. Long-term luminal change after drug-eluting stent implantation: serial angiographic follow-up study of the ZEST randomized trial. Catheter Cardiovasc Interv. 2013 Feb;81(2):274-82.
Park GM, Lee SW, Park SW, Kim YH, Yun SC, Cho YR, Ahn JM, Lee JY, Kim WJ, Park DW, Kang SJ, Lee CW, Lee BK, Lee NH, Cho YH, Suh J, Shin WY, Lee SJ, Lee SW, Park WJ, Kim HS, Lee SG, Cheong SS, Her SH, Park MW, Kim CJ, Park SJ. Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIABETES II trial. Am J Cardiol. 2013 Nov 15;112(10):1565-70
Park GM, Ahn JM, Kim DH, Kang JW, Song JM, Kang DH, Lim TH, Song JK. Distal aortic intramural hematoma: clinical importance of focal contrast enhancement on CT images. Radiology. 2011 Apr;259(1):100-8.

울산대학교병원

울산대학교병원 주메뉴

With 울산대학교병원

의료진

심장내과박경민(심장병원 병원장)

상세정보

학력

경력

직책

논문

언론

영상